AL
EDIT icon

Airain Ltd’s Editas Medicine EDIT Stock Holding History

Airain Ltd’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$255K Buy
+15,172
New +$273K 0.01% 696

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Airain Ltd's EDIT Position: Q2 2017 in Review

Airain Ltd opened a new position in Editas Medicine (EDIT) in Q2 2017: 15,172 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #696 among its holdings.

110 funds tracked by Wall St. Rank hold EDIT as of Q2 2017.

  • Airain Ltd held 15,172 shares of Editas Medicine worth $255K as of Q2 2017.
  • Editas Medicine was a new Airain Ltd position in Q2 2017.
  • Editas Medicine made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #696 holding.
  • 110 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.